Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG
Treatment and conditionWhere it standsTrials
Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1